C07D 277/48
By radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
Official title: by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
C07D277/48 (By radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof) appears on 323 US grants and 190 published applications in this corpus.
Search patents in C07D- Granted patents
- 323
- Published applications
- 190
- Assignees
- 166
- Inventors
- 853
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 11 | 0 |
| 1979 | 5 | 0 |
| 1980 | 9 | 0 |
| 1981 | 10 | 0 |
| 1982 | 15 | 0 |
| 1983 | 14 | 0 |
| 1984 | 14 | 0 |
| 1985 | 16 | 0 |
| 1986 | 8 | 0 |
| 1987 | 13 | 0 |
| 1988 | 6 | 0 |
| 1989 | 7 | 0 |
| 1990 | 11 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 10 | 0 |
| 1994 | 6 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 2 |
| 2002 | 8 | 6 |
| 2003 | 7 | 16 |
| 2004 | 5 | 18 |
| 2005 | 7 | 11 |
| 2006 | 5 | 15 |
| 2007 | 7 | 12 |
| 2008 | 5 | 15 |
| 2009 | 10 | 7 |
| 2010 | 8 | 22 |
| 2011 | 13 | 10 |
| 2012 | 10 | 10 |
| 2013 | 10 | 5 |
| 2014 | 7 | 6 |
| 2015 | 4 | 3 |
| 2016 | 2 | 2 |
| 2017 | 6 | 4 |
| 2018 | 1 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 4 |
| 2021 | 2 | 2 |
| 2022 | 2 | 1 |
| 2023 | 1 | 4 |
| 2024 | 2 | 3 |
| 2025 | 1 | 5 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulators of beta catenin and uses thereof28 Apr 2026US 12,612,396 B1Dewpoint Therapeutics, Inc.
- Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto14 Jan 2025US RE50,267 E1Arena Pharmaceuticals, Inc.
- Chromobox protein inhibitors and uses thereof29 Oct 2024US 12,129,248 B2Dana-Farber Cancer Institute, Inc.
- Aryl hydrocarbon receptor (AHR) agonists and uses thereof9 Jul 2024US 12,030,876 B2Ikena Oncology, Inc.
- Aryl hydrocarbon receptor (AHR) agonists and uses thereof21 Mar 2023US 11,608,329 B2Ikena Oncology, Inc.
- Antibacterial and synergistic active compound and use thereof27 Aug 2026US 2026/0250257 A1East China University of Science and Technology
- Amidinourea derivatives and their use in the treatment of cancer23 Jul 2026US 2026/0209196 A1Centre National De La Recherche Scientifique
- Modulators of beta catenin and uses thereof16 Jul 2026US 2026/0200909 A1Dewpoint Therapeutics, Inc.
- Cd93 inhibitors9 Jul 2026US 2026/0193245 A1UniversitäT Bern
- Modulators of beta catenin and uses thereof21 May 2026US 2026/0138977 A1Dewpoint Therapeutics, Inc.
Most cited
By later US patents
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Thiazolylacetamido cephalosporin type compounds148US 4,098,888 ATakeda Chemical Industries, Ltd. · 1978
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007
- 2-heteroatom containing urea and thiourea ACAT inhibitors127US 5,162,360 AWarner-Lambert Company · 1992